Reuters logo
1 年前
BRIEF-Audentes Therapeutics Q2 net loss $6.43
2016年8月31日 / 晚上8点22分 / 1 年前

BRIEF-Audentes Therapeutics Q2 net loss $6.43

Aug 31 (Reuters) - Audentes Therapeutics Inc

* Audentes Therapeutics Inc Q2 net loss per share, basic and diluted $6.43

* "Plan to file investigational new drug applications for three of our development programs by Q1 of 2017"

* "Expect to report preliminary data from all three programs in second half of 2017" Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below